Company intelligence / Profile preview

NerPharMa

Nerviano, Lombardy, Italynerpharma.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

NerPharMa is a contract development and manufacturing organization with strong expertise in oncology, providing GMP-compliant services for highly potent compounds. The company has supported the development and manufacture of more than 15 products on the market, including notable drugs such as eribulin mesylate for breast cancer. It offers both drug substance and drug product capabilities, handling cytotoxic/cytostatic agents from preclinical through commercial stages. Recent collaborations have led to innovative technologies in injectable formulations and delivery systems.

Therapeutic areas: Oncology
Modalities: Small moleculeCytotoxic drugCytostatic drugInjectable product (formulation)Oral solid product (formulation)
Industry: Contract Manufacturing Organization

Partnerships

Eisai China Inc.Merck KGaA/Merck SeronoArray/PfizerRocheXspray Pharma AB (Sweden)Swiss biotech company for dual chamber bag technologySpecialty pharma based in California for infusion systems

Beyond the preview

Go deeper on NerPharMa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NerPharMa.

Explore the full profile